BCR-ABL kinase down-regulates ccn3 expression in chronic myeloid leukaemia

被引：0
|
作者：
不详
机构：
来源：
CELLULAR ONCOLOGY | 2005年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] Identification of microRNAs targeting CCN3 in chronic myeloid leukaemia
    Suresh, S.
    McCallum, L.
    Irvine, A. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 75 - 75
  • [22] BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia
    Deininger, MWN
    Vieira, S
    Mendiola, R
    Schultheis, B
    Goldman, JM
    Melo, JV
    CANCER RESEARCH, 2000, 60 (07) : 2049 - 2055
  • [23] Detection of BCR-ABL transcripts in chronic myeloid leukaemia by nested PCR
    Otazú, IB
    Zalcberg, I
    Tabak, DG
    Seuánez, HN
    LEUKEMIA RESEARCH, 1999, 23 (02) : 185 - 190
  • [24] The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia
    Suresh, Sukanya
    McCallum, Lynn
    Crawford, Lisa J.
    Lu, Wan Hua
    Sharpe, Daniel J.
    Irvine, Alexandra E.
    JOURNAL OF PATHOLOGY, 2013, 231 (03): : 378 - 387
  • [25] BCR-ABL down-regulates the DNA repair protein DNA-PKcs
    Deutsch, E
    Dugray, A
    AbdulKarim, B
    Marangoni, E
    Maggiorella, L
    Vaganay, S
    M'Kacher, R
    Rasy, SD
    Eschwege, F
    Vainchenker, W
    Turhan, AG
    Bourhis, J
    BLOOD, 2001, 97 (07) : 2084 - 2090
  • [26] Is Bcr-Abl expression relevant for the survival of cancer stem cells in chronic myeloid leukaemia (CML)?
    Helgason, G. V.
    Hamilton, A.
    Myssina, S.
    Jorgensen, H. G.
    Bhatia, R.
    Modi, H.
    Schemionek, M.
    Koschmieder, S.
    Brunton, V.
    Holyoake, T. L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 72 - 72
  • [27] LONG TERM RESULTS WITH TYROSINE KINASE INHIBITORS BCR-ABL IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE
    Nunnz Yizel, Paz
    Gabriela, Silva Carreras F.
    Victoria, Vaitsekhovich
    Cecile, Mba
    Navascues Javier, Cornago
    Juan Luis, Steegmann Olmedillas
    HAEMATOLOGICA, 2016, 101 : 176 - 176
  • [28] BCR-ABL kinase domain mutations & SNPs in imatinib resistant or intolerant chronic myeloid leukaemia patients
    O'Connor, Lisa M.
    Langabeer, Stephen
    McCann, Shaun R.
    Conneally, Eibhlin
    BLOOD, 2007, 110 (11) : 699A - 700A
  • [29] CCN3, a novel growth inhibitory factor for chronic myeloid leukaemia
    Lu, W.
    McCallum, L.
    Price, S.
    Planque, N.
    Lazar, N.
    Perbal, B.
    Irvine, A. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 2 - 3
  • [30] BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia
    Clark, RE
    Christmas, SE
    LEUKEMIA & LYMPHOMA, 2001, 42 (05) : 871 - 880
12345